Moneycontrol
HomeNewsTrendsHealthCoronavirus update | AIIMS experts say virus affects nearly all organs, patient classification system needs review
Trending Topics

Coronavirus update | AIIMS experts say virus affects nearly all organs, patient classification system needs review

AIIMS director Dr Randeep Guleria said what we thought of as viral pneumonia has a lot of other manifestations which goes beyond the lungs

August 27, 2020 / 11:35 IST
Story continues below Advertisement

Representative image

SARS-Cov-2, the virus which causes COVID-19, can adversely affect nearly all organs in a human body, All India Institute of Medical Sciences (AIIMS) experts have said, highlighting the need to revisit the present system of classification of cases into mild, moderate and severe categories based solely on respiratory symptoms.

AIIMS experts, including director Dr Randeep Guleria, were discussing various possible extra-pulmonary complications of COVID-19 during the weekly 'National Clinical Grand Rounds', as per a PTI report.

Story continues below Advertisement

The experts who participated in the programme cited several cases wherein patients were labelled as asymptomatic or mild but went on to develop serious life-threatening extra-pulmonary manifestations like stroke and heart blocks.

Dr Guleria said that a lot has been learnt since the COVID-19 outbreak occurred in March and accordingly strategies are being changed from time to time. From what we thought of as viral pneumonia has a lot of other manifestations which goes beyond the lungs, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show